SRL
RPRX icon

Scientech Research LLC’s Royalty Pharma RPRX Stock Holding History

Scientech Research LLC’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,167
Closed -$254K – 815
2025
Q1 		$254K Sell
8,167
-2,068
-20% -$65.5K 0.07% 454
2024
Q4 		$261K Sell
10,235
-16,904
-62% -$448K 0.07% 449
2024
Q3 		$768K Buy
+27,139
New +$752K 0.15% 266
2024
Q2 		– Sell
-8,973
Closed -$273K – 721
2024
Q1 		$273K Buy
+8,973
New +$265K 0.14% 301

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $2.93B AUM 37.21% 1-Year Est. Return

Scientech Research LLC's RPRX Position: Q2 2025 in Review

Scientech Research LLC sold out of Royalty Pharma (RPRX) in Q2 2025, closing a stake of 8,167 shares — an estimated $254K sold.

Scientech Research LLC first reported a position in RPRX in Q1 2024 and held it in 4 quarters. The position peaked at $768K in Q3 2024. 454 funds tracked by Wall St. Rank hold RPRX as of Q2 2025.

  • Scientech Research LLC reported no remaining Royalty Pharma position as of Q2 2025 after selling out during the quarter.
  • Scientech Research LLC sold 8,167 Royalty Pharma shares in Q2 2025, an estimated $254K.
  • Scientech Research LLC first reported a position in Royalty Pharma in Q1 2024 and held it in 4 quarters.
  • Scientech Research LLC's Royalty Pharma position peaked at $768K in Q3 2024.
  • 454 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2025.

Based on Scientech Research LLC's 13F filing for Q2 2025, filed 14 Aug 2025.